Technologies Available for Licensing

For Licensing Opportunities, please contact the ORTA at


In this application is the expression and purification of a recombinant Plasmodium falciparum (3D7) MSP-1.sub.42. The method of the present invention produces a highly purified protein which retains folding and disulfide bridging of the native molecule. The recombinant MSP-1.sub.42 is useful as a diagnostic reagent, for use in antibody production, and as a vaccine.

Docket:WRAIR 01-20B

Publication/Issued No.:7,306,806

Publication/Issue Date:2007-12-11

Categories: Vaccine

More Detail:Visit USPTO.GOVExternal link


Inventor(s):LYON, J.; ANGOV, E.; COHEN, J.; VOSS, G.

For Licensing Opportunities, please contact the ORTA at

Last Modified Date: 16 May 2023

This Web site provides an introduction to the Office of Research and Technology Applications (ORTA) and contains official Government information.

Its use is intended for members of the general public, news media and Military Health System beneficiaries.

Please address questions or concerns about this Web site to the USAMRDC Public Affairs Office at: or by telephone at (301)619-2736.